Saturday, January 2, 2021
Mobile Cardiac Telemetry Systems Market | Expected to Grow at a CAGR of 9.1%
Do you like this story?
The mobile
cardiac telemetry systems market was valued at US$ 428.9 Mn in 2018,
expected to grow at a CAGR of 9.1% during the forecast period from 2019 to
2027.
Market Insights
“Increasing prevalence of CVDs along with new
FDA approval for mobile devices will enhance the market growth globally”
The global mobile cardiac telemetry systems market is
increasing effectively from 2019 to 2027 accredited to the rise in incidences
of cardiovascular diseases, new product launch, increased awareness and
acceptance of mobile devices in the end user segment on a global scale. New
lead based and patch based products with improved connectivity, and advanced
real time patient monitoring will drive the market growth in the near future.
For instance, in May 2019, VivaQuant, LLC (Minneapolis) received FDA clearance
for its RX-1 cardiac patient monitor (wearable all-in-one mobile cardiac
telemetry unit and event monitor). Additionally, VirtuOx launched
CardioCHECK, a new service to diagnose cardiac arrhythmias mainly for homecare.
Increasing awareness about new patch technology along
with the launch of advanced products with integrated solutions are key factors
driving the growth of the mobile cardiac telemetry systems market on a global
scale. The U.S. market generated maximum revenue share due to the presence of
top suppliers of mobile devices improved R&D and a significant pool of
adult patients with cardiac and other heart-related conditions. Top
manufacturers have enhanced their applications worldwide mainly in the pharmaceutical
and medical technology industry; small scale and private manufacturers are also
maximizing their manufacturing capacity with low-cost products in Asia Pacific
and Europe region.
Get Sample Copy With Covid19 Impact Analysis:
https://www.credenceresearch.com/sample-request/60147
Manufacturers are focused on maintaining standards for
monitoring devices and other applications utilized worldwide. Other external
factors include mergers and acquisitions of medical technology companies,
partnerships, new product launch, FDA approval of new products, promotional
activities, awareness for higher safety & control and activities related to
sales promotions, technology expansion, and research and development. The
market players are also aware of the cost containment in the regions with Asia
Pacific, Africa, and the Middle East and emphasizing on launch of pocket-friendly
devices.
Key Market Movements:
• Globally, the mobile cardiac telemetry systems market
is growing at a CAGR of 9.1% for the period from 2019 to 2027
• The speedy expansion of hospital infrastructure in the
emerging nations and increasing medical tourism will drive the market growth in
the Asia Pacific and Latin America regions. For instance, the total number of
hospitals in Brazil expanded from 6800 in 2015 to 6807 in 2017.
• The perceptible growth factors comprise increasing
prevalence of cardiovascular diseases globally, FDA approval of new mobile
cardiac systems (mainly in the U.S. market), rising elderly population, and
enhanced awareness related to top applications in the cardiac telemetry systems
for quality outcomes and real-time patient cardiac analysis
• Market restrictions include high cost of patches, very
less technology expansion in the developing nations, unstructured reimbursement
scenario and less awareness or less product penetration in the overall cardiac
monitoring segment
Key Industry Developments
- In
March 2019, VirtuOx (home respiratory diagnostic provider) launched a new
service named CardioCHECK to diagnose cardiac arrhythmias.
- Biotricity
Inc. (medical diagnostic and healthcare technology company) received its
510(k) clearance for its Bioflux device with the U.S. FDA.
List of Companies Covered:
• Medtronic Plc
• Medicomp Inc.
• BioTelemetry Inc.
• ZOLL Medical Corporation
• Welch Allyn
• ScottCare Corporation Solution
• Siemens Healthcare Pvt. Ltd
• Biotricity Inc.
• Preventice Solutions
• Telerhythmics LLC.
• Applied Cardiac Systems Inc.
• Philips Benelux
Get Sample Copy With Covid19 Impact Analysis:
https://www.credenceresearch.com/sample-request/60147
DoC: https://issuu.com/alchemymarketresearch/docs/mobile_cardiac_telemetry_systems_market.docx
About Us
Credence Research is a worldwide market research and counseling firm that
serves driving organizations, governments, non-legislative associations, and
not-for-benefits. We offer our customers some assistance with making enduring
enhancements to their execution and understand their most imperative
objectives.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com
0 Responses to “Mobile Cardiac Telemetry Systems Market | Expected to Grow at a CAGR of 9.1%”
Post a Comment